Stay updated on Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.

Latest updates to the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded a new 'Last Update Posted (Estimated)' timestamp and removed the plain 'Last Update Posted' field in the Study Record Dates section. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check11 days agoChange DetectedAdded Banner North Colorado Medical Center - Loveland Campus to the list of study locations and removed Banner McKee Medical Center. Updated the page's last update timestamp to reflect these changes.SummaryDifference0.1%

- Check18 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page.SummaryDifference0.0%

- Check25 days agoChange DetectedAdded a PubMed auto-fill note and updated the revision to v3.3.1, while removing the previous PubMed-based description (v3.2.0).SummaryDifference0.0%

- Check32 days agoChange DetectedRemoved the site-wide notice about government funding lapse and NIH operations status from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check39 days agoChange DetectedRush MD Anderson Cancer Center was added as a study site (2025-10-31) and Rush University Medical Center was removed (2025-10-15); these location changes affect where eligible participants can enroll.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemotherapy in Endometrial Cancer Clinical Trial page.